Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Resistance and Testosterone in Non-Diabetic Postmenopausal Women
NCT00123110Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2005
- Primary completion
- Dec 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in insulin resistance (IR) comparing Metformin, Leuprolide and Placebo (3 arms). Primary endpoints: Percent Change in Free Testosterone at 12 weeks and Change in Insulin Sensitivity at 12 weeks. Started Jul 2005; status: completed.
02
Drugs
metforminleuprolide
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT00123110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123110.